You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.


Test Information

Power Up for the Future With plus 

Fast, accurate, and actionable test results for this respiratory season

New Test Designed to Be More Robust Against Mutations

Announcing Xpert® Xpress CoV-2/Flu/RSV plus

Introducing our next-generation Xpert Xpress CoV-2/Flu/RSV plus test, designed to include a more robust three-gene detection of CoV-2 to enable virus variant detection and further mitigate the possible effects of viral mutations.

Enter the upcoming respiratory virus season with the confidence of a single test to detect and differentiate SARS-CoV-2, Flu A, Flu B, and RSV.  The test can provide rapid on-demand detection of SARS-CoV-2 as soon as 25 minutes for positive results* and provide results for all four pathogens in just 36 minutes with less than a minute of hands-on time.

CE-IVD in Vitro Diagnostic Medical Device.  May not be available in all countries.
*With early assay termination for positives when running SARS-CoV-2 only.  Full run time is 36 mins.

Learn more

Access Product Resources

Connect To Better Outcomes

Request Info

1. What is Cepheid doing to aid in the detection of viral mutation?

For the upcoming respiratory season in the Northern Hemisphere, Cepheid has launched a test that provides rapid, accurate detection and differentiation of SARS-CoV-2, Flu A, Flu B, and RSV in as little as 36 minutes, while offering three gene targets for SARS-CoV-2 to enable detection of current and future variants of the SARS-CoV-2 virus. The test has been designed for broader coverage to mitigate the possible effects of viral genetic drift.

2. How fast are Cepheid’s SARS-CoV-2 tests?

Cepheid’s tests are well suited for pandemic response. Many of our GeneXpert® Systems are in hospital labs and other near-patient settings. From the time a sample (such as a nasopharyngeal swab) is taken, a result can be obtained in less than an hour. We call this “sample to answer” and the samples can be loaded as they are received for true on-demand testing. It takes less than a minute to prepare the cartridge with the patient sample. The new Xpert Xpress CoV-2/Flu/RSV plus test can report a positive result for SARS-CoV-2 as soon as 25 minutes* after a test cartridge is loaded onto the system.

3. How do I get a GeneXpert System at my facility?

Click the green Request Information button at the top of this page to be connected with your local Cepheid Sales Representative.

4. Which strains of coronavirus are detected by Cepheid’s SARS-CoV-2 tests?

The tests are designed to detect the SARS-CoV-2 strain of the coronavirus, the virus that causes COVID-19. Xpert Xpress CoV-2/Flu/RSV plus uses the E, N2, and RdRP genes to detect SARS-CoV-2, and also detects and differentiates Flu A, Flu B, and RSV.

5. Which specimen types are accepted^?

Xpert Xpress CoV-2/Flu/RSV plus supports a variety of sample types including nasopharyngeal and anterior nasal swabs in UTM/VTM, saline, or eNAT. Additional information, including sample types for Cepheid’s other SARS-CoV-2 tests, can be found on the product resource page at and in the package inserts.^

CE-IVD In Vitro Diagnostic Medical Device. May not be available in all countries.
* For positives when running SARS-CoV-2 only on Xpert Xpress CoV-2/Flu/RSV plus; otherwise, the test will have a runtime of approximately 36 minutes.
^See package insert for details; sample types may vary by system and regulatory status. Nasal Wash / Aspirate are supported on GeneXpert DX and GeneXpert Infinity Systems.

Learn About Cepheid GeneXpert® Systems

GeneXpert® Infinity Systems

“Load and go” technology delivers total automation for up to 2,000 tests a day.

Explore the potential

GeneXpert® Systems

Available in 2, 4 or 16-module configurations that all use the same cartridge technology.

Explore the potential
Back to Top